The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Cryotherapy for the treatment of liver metastases.

Description

Cancer cells can spread from where they start (the ‘primary tumour’) to other parts of the body to form one or more ‘secondary tumours’, which are also known as ‘metastases’. Liver metastases occur when cancer spreads from other parts of the body to the liver.

Cryotherapy is a process that uses cold temperatures to destroy cancer cells; it is applied directly to the tumour through a special needle.

Coding recommendations

Open cryotherapy to liver metastases:

J03.2 Destruction of lesion of liver NEC

Y13.2 Cryotherapy to lesion of organ NOC

Percutaneous cryotherapy to liver metastases:

J12.8 Other specified other therapeutic percutaneous operations on liver

Y13.2 Cryotherapy to lesion of organ NOC

Y53.- Approach to organ under image control

Note: Codes within category Y53.-  are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.

In addition the ICD-10 code C78.7 Secondary malignant neoplasm of liver would be recorded.

  • National Institute for Health and Care Excellence (NICE) accreditation logo